Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Active Prosthetic Valve Endocarditis: The Clinical Profile, Laboratory Findings and Mid-term Surgical Results

활동성 인공판막 심내막염: 임상 양상, 검사 소견 및 중기 수술 성적

  • Kim, Hwan-Wook (Department of Thoracic and Cardiovascular Surgery, Seoul Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Joo, Seok (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Hee-Jung (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choo, Suk-Jung (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Song, Hyun (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Jae-Won (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Chung, Cheol-Hyun (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • 김환욱 (가톨릭대학교 의과대학 서울성모병원 흉부외과학교실) ;
  • 주석 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 김희중 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 주석중 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 송현 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 이재원 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 정철현 (울산대학교 의과대학 서울아산병원 흉부외과학교실)
  • Published : 2009.08.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Prosthetic valve endocarditis usually presents with clinical symptoms that are more severe than native valve endocarditis, and prosthetic valve endocarditis shows the spread of infection into the surrounding tissue as well as into the superficial endocardial layers. The postoperative prognosis is especially poor for valve re-replacement for the cases of active endocarditis that are unable to receive a full-course of pre-antibiotic therapy due to complications and the ensuing clinical aggravation. The aim of this study was to evaluate the clinical profiles, laboratory findings and mid-term surgical results of active prosthetic valve endocarditis. Material and Method: Among the 276 surgically treated infective endocarditis patients who were treated during the period from January 1998 to July 2008, 31 patients were treated for prosthetic valve endocarditis. Among these patients, 24 received surgical treatment for an 'active' state, and they were selected for evaluation. Result: The most frequently encountered symptom was a febrile sensation. Eight cases (33.3%) were accompanied by systemic thromboembolism, among which 5 cases (20.8%) had an affected central nervous system. 'Vegetations' were most commonly found on transesophageal echocardiography, and the 'Staphylococcus species' were the most frequent pathogens. There were 4 deaths in the immediate postoperative period, and an additional 4 patients died during the follow-up period (Mean$\pm$SD, 42.1$\pm$36.9 months). The cumulative survival rate was 79% at 1 year, 73% at 3 years, 66% at 5 year, and 49.5% at 7 years. Conclusion: The cases of active prosthetic valve endocarditis that were unable to receive a full course of preoperative antibiotics therapy generally have a poor prognosis. Nevertheless, early surgery and extensive resection of all the infected tissue is pivotal in improving the survival rate of patients with surgically treated active prosthetic valve endocarditis.

배경: 인공판막 심내막염은 자연판막 심내막염보다 초기 임상양상이 불량하고, 심내막의 감염 뿐 아니라 주변 조직으로 염증 파급이 용이하다. 특히, 합병증을 동반하여 악화된 임상양상으로 술 전 충분한 항생제 치료를 기대할 수 없는 상태(활동성 심내막염)에서 판막 재치환술을 시행하는 경우는 만족스럽지 못한 술 후 예후를 가진다. 본 연구는 활동성 인공판막 심내막염의 임상 양상, 검사 소견 및 중기 수술 성적 알아보기 위해 수행되었다. 대상 및 방법: 1998년 1월부터 2008년 7월까지 감염성 심내막염으로 진단 및 수술이 이루어진 276명의 환자 중 인공판막 심내막염으로 수술이 이루어진 경우는 31명이었다. 이 중 24명의 활동성 인공판막 심내막염 환자를 연구 대상으로 하였다. 결과: 열감이 가장 흔한 임상증상이었으나, 전신성 색전증을 동반한 경우도 8예(33.3%)였으며, 이 중 5예(20.8%)는 중추신경계가 이환되었다. 경식도 초음파 검사상 우종(vegetation)이 가장 많이 관찰된 소견이며, 포도상 구균(Staphylococcus species)이 배양된 주된 원인 균주였다. 42.1$\pm$36.9달의 평균 추적 관찰 기간 동안 조기사망 4예, 만기사망 4예 있었으며, 누적 생존율은 1년 후에는 79%, 3년 후에는 73%, 5년 후에는 66%, 7년 후에는 49.5%였다. 결론: 악화된 임상양상 등의 이유로 술 전 충분한 항생제 치료를 기대할 수 없는 활동성 인공판막 심내막염은 술 후 불량한 예후를 가진다. 그럼에도 불구하고, 조기 수술은 물론, 정상 조직이 노출이 될 때까지 광범위한 염증 조직 제거하는 것이 환자의 생존율을 높일 수 있는 방법이라 생각된다.

Keywords

References

  1. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valve. N Engl J Med 1996;335:407-416 https://doi.org/10.1056/NEJM199608083350607
  2. Romano G, Carozza A, Della Corte A, et al. Native versus primary prosthetic valve endocarditis; comparison of clinical features and long-term outcome in 353 patients. J Heart Valve Dis 2004;13:200-208
  3. Aranki SF, Santini F, Adams DH, et al. Aortic valve endocarditis. Determenants of early survival and late morbidity. Circulation 1994;90;175-182
  4. Calderwood SB, Swinski LA, Karchmer AW, et al. Prosthetic valve endocarditis; analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg 1986;92: 776-783
  5. Piper C, Kopfer R, Horskotte D. Prosthetic valve endocarditis. Heart 2001;85:590-593 https://doi.org/10.1136/heart.85.5.590
  6. Lopez J, Revilla A, Vilacosta I, et al. Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J 2007;28:760-765 https://doi.org/10.1093/eurheartj/ehl486
  7. Douglas JL, Cobbs CG. Prosthetic valve endocarditis. In: Kaye D. Infective endocarditis. 2nd ed. New York: Raven Press. 1992;375-396
  8. Calderwood SB, Swinski LA, Waternaux CM, et al. Risk factors for the development of prosthetic valve endocarditis. Circulation 1985;72:31-37 https://doi.org/10.1161/01.CIR.72.1.31
  9. Horstkotte D, Follath F, Graevenitz A, et al. Late prosthetic valve endocarditis. Eur Heart J 1995;16(suppl B):39-47 https://doi.org/10.1093/eurheartj/16.suppl_B.39
  10. Moon MR, Miller DC, Moore KA, et al. Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg 2001;71: 1164-1171 https://doi.org/10.1016/S0003-4975(00)02665-5
  11. Vlessis AA, Khaki A, Grunkemeier GL, Li HH, Starr A. Risk, diagnosis and management of prosthetic valve endocarditis: a review. J Heart Valve Dis 1997;6:443-465
  12. Fang G, Keys TF, Gentry LO, et al. Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective multicenter study. Ann Intern Med 1993;119: 560-567 https://doi.org/10.7326/0003-4819-119-7_Part_1-199310010-00003
  13. Ivert TS, Dismukes WE, Cobbs CG, Blackstone EH, Kirklin JW, Bergdahl LA. Prosthetic valve endocarditis. Circulation 1984;69:223-232 https://doi.org/10.1161/01.CIR.69.2.223
  14. Hyde JA, Darouiche RO, Costerton JW. Strategies for prophylaxis against prosthetic valve endocarditis: a review article. J Heart Valve Dis 1998;7:316-326
  15. Salgado AV, Furlan AJ, Keys TF, Nickols TR, Beck GJ. Neurologic complications of endocarditis: a 12-year experience. Neurology 1989;39:173-178 https://doi.org/10.1212/WNL.39.2.173
  16. Wilson WR, Danielson GK, Giulani ER, Geraci JE. Prosthetic valve endocarditis. Mayo Clin Proc 1982;57:155-161
  17. Vilacosta I, Graupner C, San Roman JA, et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002;39:1489-1495 https://doi.org/10.1016/S0735-1097(02)01790-4
  18. Wilson WR, Geraci JE, Danielson GK, et al. Anticoagulation therapy and central nervous system complications in patients with prosthetic valve endocarditis. Circulation 1978;57:1004-1007 https://doi.org/10.1161/01.CIR.57.5.1004
  19. Davenport J, Hart RG. Prosthetic valve endocarditis 1976- 1987: antibiotics, anticoagulation, and stroke. Stroke 1990; 21:993-999 https://doi.org/10.1161/01.STR.21.7.993
  20. Carpenter JL, McAllister CK. Anticoagulation in prosthetic valve endocarditis. South Med J 1983;76:1372-1375 https://doi.org/10.1097/00007611-198311000-00011
  21. Ruttmann E, Willeit J, Ulmer H, et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 2006;37:2094-2099 https://doi.org/10.1161/01.STR.0000229894.28591.3f
  22. Piper C, Wiemer M, Schulte HD, Horstkotte D. Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 2001;10:703-711
  23. Eishi K, Kawazoe W, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg 1995;110: 1745-1755 https://doi.org/10.1016/S0022-5223(95)70038-2
  24. Gillinov AM, Shah RV, Curtis WE, et al. Valve replacement in patients with endocarditis and neurologic deficit. Ann Thorac Surg 1996;61:1125-1130 https://doi.org/10.1016/0003-4975(96)00014-8